ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation

Journal of Cell Biology

Volumn 147, Issue 1, 1999, Pages 77-87

  Jones, Frank E ^a,b   Welte, Thomas ^a   Fu, Xin Yuan ^a   Stern, David F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SCRANTON   (United States)

Author keywords

Dominant negative mutant; ErbB4; Mammary gland development; Stat5; Transgenic mice

Indexed keywords

ACID PROTEIN; ALPHA LACTALBUMIN; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; STAT5 PROTEIN;

ARTICLE; BREAST DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LACTATION; MAMMARY GLAND FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; CELL NUCLEUS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK PROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; PREGNANCY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSGENES;

EUKARYOTA; MUS MUSCULUS;

EID: 0033523775     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.147.1.77     Document Type: Article

References (64)

1. Alroy, I., and Y. Yarden. 1997. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410:83-86.
2. Bacus, S.S., C.R. Zelnick, G. Plowman, and Y. Yarden. 1994. Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers: implication for tumor biology and clinical behavior. Am. J. Clin. Pathol. 102: S13-S24.
3. Bacus, S.S., D. Chin, Y. Yarden, C.R. Zelnick, and D.F. Stern. 1996. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am. J. Pathol. 148: 549-558.
4. Berlanga, J.J., J.P. Garcia-Ruiz, M. Perrot-Applanat, P.A. Kelly, and M. Edery. 1997. The short form of the prolactin (PRL) receptor silences PRL induction of the β-casein gene promoter. Mol. Endocrinol. 11:1449-1457.
5. Bobrow, L.G., R.R. Millis, L.C. Happerfield, and W.J. Gullick. 1997. c-erbB-3 protein expression in ductal carcinoma in situ of the breast. Eur. J Cancer. 33:1846-1850.
6. Boutin, J.M., C. Jolicoeur, H. Okamura, J. Gagnon, M. Edery, M. Shirota, D. Banville, I. Dusanter-Fourt, J. Djiane, and P.A. Kelly. 1988. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor family. Cell. 53:69-77.
7. Coleman, S.. G.B. Silberstein, and C.W. Daniel. 1988. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev. Biol. 127:304-315.
8. David, M., L. Wong, R. Flavell, S.A. Thompson, A. Wells, A.C. Lamer, and G.R. Johnson. 1996. STAT activation by epidermal growth factor (EGF) and amphiregulin: requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem. 271:9185-9188.
9. Davis, J.A., and D.I.H. Linzer. 1989. Expression of multiple forms of the prolactin receptor in mouse liver. Mol. Endocrinol. 3:674-680.
10. Deckard-Janatpour, K., W.J. Muller, L.A. Chodosh, H.P. Gardner, S.T. Marquis, R. Coffey, and R. D. Cardiff. 1997. Differential expression of the neu transgene in murine mammary tissues. Int. J. Oncol. 11:235-241.
11. Dickson, R.B., and M.E, Lippman. 1995. Growth factors in breast cancer. Endocrine Rev. 16:559-589.
12. Faerman, A., I. Barash, R. Puzis, M. Nathan, D.R. Hurwitz, and M. Shani. 1995. Dramatic heterogeneity of transgene expression in the mammary gland of lactating mice: a model system to study the synthetic activity of mammary epithelial cells. J. Histochem. Cytochem. 43:461-470.
13. Fowler, K.J., F. Walker, W. Alexander, M.L. Hibbs, B.C. Nice, R.M. Bohmer, G.B. Mann, C. Thumwood, R. Maglitto, J.A. Danks, et al. 1995. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl Acad. Sci. USA. 92:1465-1469.
14. Garcia, R., C-L. Yu, A. Hudnall, R. Catlett, K.L. Nelson, T. Smithgall, D.J. Fujita, S.P. Ethier, and R. Jove. 1997. Constituitive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8:1267-1276.
15. Gassmann, M., F. Casagranda, D. Orioli, H. Simon, C. Lai, R. Klein, and G. Lemke. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature. 378:390-394.
16. Gouilleux. F., H. Wakao, M. Mundt, and B. Groner. 1994. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 13:4361-4369.
17. Groner, B., and F. Gouilleux. 1995. Prolactin-mediated gene activation in mammary epithelial cells. Curr. Opin. Genet. Dev. 5:587-594.
18. Gullick, W.J., and R. Srinivasan. 1998. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer. Breast Cancer Res. Treat. 52:43-53.
19. Hennighausen, L.G., and A.E. Sippel. 1982. Mouse whey acidic protein is a novel member of the family of "four-disulfide core" proteins. Nucleic Acids Res. 10:2677-2684.
20. Hennighausen, L., G.W. Robinson, K.-U. Wagner, and X. Liu. 1997. Prolactin signaling in mammary gland development. J. Biol. Chem. 272:7567-7569.
21. Hynes, N.B., and D.F. Stern. 1994. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta. 1198:165-184.
22. Jahn, G.A., M. Edery, L. Belair, P.A. Kelly, and J. Djiane. 1991. Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation. Endocrinology. 128:2976-2984.
23. Johnson, H.M., B.A. Torres, M.M. Green, B.E. Szente, K.I. Siler, J. Larkin III, and P.S. Subramaniam. 1998. Cytokine-receptor complexes as chaperones for nuclear translocation of signal transducers. Biochem. Biophys. Res. Commun. 244:607-614.
24. Johnson, L.R., S.A. McCormack, C.-H. Yang, S.R. Pfeffer, and L.M. Pfeffer. 1999. EGF induces nuclear translocation of STAT2 without tyrosine phosphorylation in intestinal epithelial cells. Cell Physiol. 45:C419-C425.
25. Jones, F.E., and D.F. Stern. 1999. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene. 18:3481-3490.
26. Jones, F.E., D.J. Jerry, B.C. Guarino, G.C. Andrews, and D.F. Stern. 1996. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ. 7:1031-1038.
27. Kazansky, A.V., B. Raught, S.M. Lindsey, and Y.-f. Wang. 1995. Regulation of mammary gland factor/Stat5 during mammary gland development. Mol. Endocrinol. 9:1598-1609.
28. Kenney, N.J., G.H. Smith, K. Rosenberg, M.L. Cutler, and R.B. Dickson. 1996. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ. 7:1769-1781.
29. Knowlden, J.M., J.M.W. Gee, L.T. Seery, L. Farrow, W.J. Gullick, I.O. Ellis, R.W. Blarney, J.F.R. Robertson, and R.I. Nicholson. 1998. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene. 17:1949-1957.
30. Lemoine, N.R., D.M. Barnes, D.P. Hollywood, CM. Hughes, P. Smith. E. Dublin, S.A. Prigent, W.J. Gullick, and H.C. Hurst. 1992. Expression of the ERBB3 gene product in breast cancer. Br. J. Cancer. 66:1116-1121.
31. Lesueur, L., M. Edery, S. Ali, J. Paly, P.A. Kelly, and J. Djiane. 1991. Comparison of long and short forms of the prolactin receptor on prolactin-induced milk gene transcription. Proc. Natl. Acad. Sci. USA. 88:824-828.
32. Li, W., J.W. Park, A. Nuijens, M.X. Sliwkowski, and G.-A. Keller. 1996. Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene. 12:2473-2477.
33. Liu, X., G.W. Robinson, and L. Hennighausen. 1996a. Activation of StatSa and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol. 10:1496-1506.
34. Liu, X., G.W. Robinson, K.-U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen. 1996b. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179-186.
35. Luetteke, N.C., T.H. Oui, S.E. Fenton, K.L. Troyer, R.F. Riedel, A. Chang, and D.C. Lee. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development. 126:2739-2750.
36. May, P., C. Gerhartz, B. Heesel, T. Weite, W. Doppler, L. Graeve, F. Horn, and P.C. Heinrich. 1996. Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation. FEBS Lett. 394: 221-226.
37. Miller, A.D., and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7:980-990.
38. Mizoguchi, Y., H. Yamaguchi, F. Aoki, J. Enami, and S. Sakai. 1997. Corticosterone is required for the prolactin receptor gene expression in the late pregnant mouse mammary gland. Mol. Cell. Endocrinol. 132:177-183.
39. Nagano, M., and P.A. Kelly. 1994. Tissue distribution and regulation of rat prolactin receptor gene expression: quantitative analysis by polymerase chain reaction. J. Biol. Chem. 269:13337-13345.
40. Naidu, R., M. Yadav, S. Nair, and M.K. Kutty. 1998. Expression of c-ErbB3 protein in primary breast carcinomas. Br. J. Cancer. 78:1385-1390.
41. Niemann, C., V. Brinkmann, E. Spitzer, G. Hartmann, M. Sachs, H. Naundorf, and W. Birchmeier. 1998. Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J. Cell Biol. 143:533-545.
42. Olayioye, M.A., I. Beuvink, K. Horsch, J.M. Daly, and N.E. Hynes. 1999. ErbB receptor-induced activation of Stat transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem. 274:17209-17218.
43. Ornitz, D.M., R.W. Moreadilh, and P. Leder. 1991. Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc. Natl. Acad. Sci. USA. 88:698-702.
44. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA. 90:1746-1750.
45. Quinn, C.M., J.L. Ostrowski, S.A. Lane, D.P. Loney, J. Teasdale, and E.A. Benson. 1994. c-erbB-3 protein expression in human breast cancer; comparison with other tumour variables and survival. Histopathology. 25:247-252.
46. Richer, J.K., CA. Lange, N.G. Manning, G. Owen, R. Powell, and K.B. Horwitz. 1998. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. J. Biol. Chem. 273:31317-31326.
47. Riese, D.J., II, and D.F. Stern. 1998. Specificity within the EGFfamily/ErbB receptor family signaling network. BioEssays. 20:41-48.
48. Riese, D.J., II, TM. van Raaij, G.D. Plowman, G.D. Andrews, and D.F. Stern. 1995. Cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 15:5770-5776.
49. Ruff-Jamison, S., K. Chen, and S. Cohen. 1995. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc Natl. Acad. Sci. USA. 92:4215-4218.
50. Schindler, C., and J.E. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
51. Schroeder, J.A., and D.C. Lee. 1998. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 9:451-464.
52. Sebastian, J., R.G. Richards, W.P. Walker, J.F. Wiesen, Z. Werb, R. Derynck, Y.K. Horn, G.R. Cunha, and R.P. DiAugustine. 1998. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ. 9:777-785.
53. Shirota, M., D. Banville, S. Ali, C. Jolicoeur, J.M. Boutin, M. Edery, J. Dijane, and P.A. Kelly. 1990. Expression of two forms of prolactin receptor in rat ovary and liver. Mol. Endocrinol. 4:1136-1143.
54. Srinivasan. R., R. Poulsom, H.C. Hurst, and W.J. Gullick. 1998. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J. Pathol. 185:236-245.
55. Stern, D.F., P.A. Heffernan, and R.A. Weinberg. 1986. p185, a product of the neu proto-oncogene, is a receptor like protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6:1729-1740.
56. Teglund, S., C. McKay, E. Schuetz, J.M. vanDeursen, D. Stravopodis, D. Wang. M. Brown, S. Bodner, G. Grosveld, and J.N. IhIe. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:841-850.
57. Vilotte, J.-L., and S. Soulier. 1992. Isolation and characterization of the mouse α-lactalbumin-encoding gene: interspecies comparison, tissue- and stage-specific expression. Gene. 119:287-292.
58. Vonderhaar, B.K. 1987. Local effects of EGF, α-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo. J. Cell. Physiol. 132:581-584.
59. Wakao, H., N.M. Schmitt, and B. Groner. 1992. Mammary gland-specific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 kDa. J. Biol. Chem. 267:16365-16370.
60. Wakao, H., F. Gouilleux, and B. Groner. 1994. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO (Eur. Mol. Biol. Organ.) J. 13: 2182-2191.
61. Weite, T., D. Leitenberg, B.N. Dittel, B.K. al-Ramadi, B. Xie, Y.E. Chin, C.A. Janeway, A.L.M. Bothwell, K. Bottomly, and X.-Y. Fu. 1999. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science. 283:222-225.
62. Wiesen, J.F., P. Young, Z. Werb, and G.R. Cunha. 1999. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development. 126:335-344.
63. Xie, W., A. J. Paterson, E. Chin, L.M. Nabell, and J.E. Kudlow. 1997. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol. 11:1766-1781.
64. Yang, Y., E. Spitzer, D. Meyer, M. Sachs, C. Niemann, G. Hartmann, K.M. Weidner, C. Birchmeier, and W. Birchmeier. 1995. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131:215-226.